Previous Close | 7.64 |
Open | 7.56 |
Bid | 8.42 x 0 |
Ask | 8.43 x 0 |
Day's Range | 7.56 - 8.62 |
52 Week Range | 3.84 - 12.85 |
Volume | |
Avg. Volume | 614,369 |
Market Cap | 460.791M |
Beta (5Y Monthly) | 2.71 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
ACB and MedReleaf Australia launch premium medical cannabis oils, offering tailored cannabinoid formulations for patient care.
This Canadian pot stock has defied the broader downturn among its peer group in 2024.